1-9 of 9
Authors: Yu Long
Sort by
Journal Article
TMIC-49. ABROGATING CD70 EXPRESSION IN GBM RESULTS IN A REDUCED IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT Free
Haipeng Tao and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi258, https://doi.org/10.1093/neuonc/noz175.1083
Published: 11 November 2019
Journal Article
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition Free
Aida Karachi and others
Neuro-Oncology, Volume 21, Issue 6, June 2019, Pages 730–741, https://doi.org/10.1093/neuonc/noz015
Published: 22 January 2019
Journal Article
DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM Free
Yu Long and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.320
Published: 05 November 2018
Journal Article
IMMU-56. CXCR1/2 MODIFIED CARs CO-OPT RADIATION-INDUCED IL-8 FOR ENHANCED CHEMOTAXIS OF THE CAR T CELLS AND MAXIMAL ANTI-TUMOR EFFICACY Free
Linchun Jin and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi134, https://doi.org/10.1093/neuonc/noy148.559
Published: 05 November 2018
Journal Article
CD70, a novel target of CAR T-cell therapy for gliomas Free
Linchun Jin and others
Neuro-Oncology, Volume 20, Issue 1, January 2018, Pages 55–65, https://doi.org/10.1093/neuonc/nox116
Published: 23 June 2017
Journal Article
IMST-24. COMBINATION OF VEGF-A AND PD-1 BLOCKADE MAY ENHANCE ANTITUMOR EFFICACY IN GBM Free
Yu Long and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi91, https://doi.org/10.1093/neuonc/now212.380
Published: 07 November 2016
Journal Article
IMST-25. CD70—A NOVEL TARGET OF CAR-T-CELL THERAPY FOR GLIOMAS Free
Linchun Jin and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi91–vi92, https://doi.org/10.1093/neuonc/now212.381
Published: 07 November 2016
Journal Article
IMST-27. CD70–A CRITICAL MEDIATOR OF TUMOR PROGRESSION AND IMMUNOSUPPRESSION IN GLIOMAS Free
Haitao Ge and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi92, https://doi.org/10.1093/neuonc/now212.383
Published: 07 November 2016
Journal Article
IMPS-42CD70—A KEY DRIVER OF CHEMOKINE-MEDIATED IMMUNE SUPPRESSION AND INDICATOR OF NEGATIVE PROGNOSIS FOR GLIOBLASTOMA Free
Haitao Ge and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v122, https://doi.org/10.1093/neuonc/nov217.41
Published: 09 November 2015
Advertisement
Advertisement